<DOC>
	<DOC>NCT02129803</DOC>
	<brief_summary>This study is a single center, randomized pilot study to evaluate the clinical effectiveness of nasal high flow 20LPM humidification therapy in subjects with Cystic Fibrosis.</brief_summary>
	<brief_title>Evaluating High Flow Humidification Therapy in Patients With Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Confirmed diagnosis of CF Hospital admission for acute pulmonary exacerbation of CF (using Fuchs criteria 4/10) 10 years of age and older Subject is able to comply with the procedures scheduled in the protocol Signed informed consent form Receipt of any aerosolized experimental or investigational drugs within 1 month of enrollment Subject had ear, nose, and throat (ENT) surgery, nasal bleeding, or nasal polyps within 6 months prior to study Subject is unlikely to comply with the procedures scheduled in the protocol Inability to give informed consent Subject requires supplemental oxygen History of obstructive sleep apnea History of pressure headaches requiring therapy within one month of enrollment Any other medical or psychological condition in which the study doctor(s) believe(s) would inhibit the individual from being an appropriate study subject.</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Cystic Fibrosis, high flow 20 liters per minute (LPM) humidification therapy</keyword>
</DOC>